The Patent Finder

Nasal Administration

Optinose Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/GB2008/001226, filed Apr 7, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,875,704Nasal Administration
In force
 · High confidence
OptiNose Inc.In force
High confidence
US 10,722,667Nasal Administration
In force
 · High confidence
OptiNose Inc.In force
High confidence
US 9,649,456Nasal Administration
In force
 · High confidence
OptiNose Inc.In force
High confidence
Application 14/842,772Nasal Administration
Abandoned
Abandoned Feb 3, 2017
OptiNose AsAbandonedAbandoned Feb 3, 2017
Application 16/939,694Nasal Administration
Abandoned
Abandoned Apr 24, 2024
OptiNose Inc.AbandonedAbandoned Apr 24, 2024
Application 18/643,434Nasal Administration
Pending
Not granted
OptiNose, Inc.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Optinose Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited